Neuronet convenes 8th meeting of its Scientific Coordination Board
On 30 March, the Innovative Medicines Initiative (IMI) funded Neuronet Coordination and Support Action convened
IMPRiND
Neuronet publishes series of project introduction videos during Brain Awareness Week
The Neuronet programme launched a series of short introduction videos of the various Innovative Medicines
Neuronet convenes annual event on European research collaboration in Alzheimer’s disease & beyond
Neuronet, a coordination and support action funded by the Innovative Medicines Initiative (IMI), brings together
Hierarchical classification of tauopathies complements clinical diagnosis of neurodegenerative diseases
The ordered assembly of tau protein into filaments characterizes several neurodegenerative diseases, which are called
Neuronet launches its social media campaign “Programme impact analysis – where we are and where we need to go”
The Neuronet project is setting up an efficient platform to boost collaboration across research projects
A stem cell-based model offers new insights into the mechanisms of neuronal loss in Parkinson’s disease
Project Coordinator of the Innovative Medicines Initiative’s IMPRiND project Dr Tofaris and his team at
Communication representatives of neurodegeneration research projects exchange on best practices
On 7 May, representatives of 12 Innovative Medicines Initiative neurodegeneration research projects met virtually to
Neuronet convenes 6th meeting of its Scientific Coordination Board
On 22 March, the Innovative Medicines Initiative (IMI) funded Neuronet Coordination and Support Action convened
EFPIA publishes a guest blog on IMI impact: collaboration is key to dementia challenge
On November 3rd, the European Federation of Pharmaceutical Industries and Associations (EFPIA) published a blog
IMPRiND researchers describe the structures of alpha-synuclein filaments in MSA and DLB
Michel Goedert, a partner on the IMPRiND project, has recently published an article in Nature,